To determine if vaginal spermicides actually reduce the spread of STDs

    The FDA will require new clinical testing to determine if vaginal spermicides actually reduce the spread of STDs.

    This is important. STDs now account for 5 of the ten most frequently reported diseases.

    Spermicides have antimicrobial effects in vitro...but not much is known about how well they work in actual use.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote